- Report
- September 2025
- 183 Pages
Global
From €4026EUR$4,500USD£3,443GBP
- Report
- August 2026
- 504 Pages
Global
From €5234EUR$5,850USD£4,476GBP
- Report
- April 2026
- 200 Pages
Global
From €2675EUR$2,990USD£2,288GBP
- Report
- January 2026
- 189 Pages
Global
From €3172EUR$3,545USD£2,713GBP
€3524EUR$3,939USD£3,014GBP
- Report
- July 2026
- 120 Pages
Global
From €4340EUR$4,850USD£3,711GBP
- Report
- November 2025
- 210 Pages
Global
From €4340EUR$4,850USD£3,711GBP
- Report
- August 2026
- 181 Pages
Global
From €3172EUR$3,545USD£2,713GBP
€3524EUR$3,939USD£3,014GBP
- Report
- August 2026
- 185 Pages
Global
From €3172EUR$3,545USD£2,713GBP
€3524EUR$3,939USD£3,014GBP
- Report
- August 2026
- 182 Pages
Global
From €3172EUR$3,545USD£2,713GBP
€3524EUR$3,939USD£3,014GBP
- Report
- August 2026
- 195 Pages
Global
From €3172EUR$3,545USD£2,713GBP
€3524EUR$3,939USD£3,014GBP
- Report
- August 2026
- 195 Pages
Global
From €3172EUR$3,545USD£2,713GBP
€3524EUR$3,939USD£3,014GBP
- Report
- February 2026
- 250 Pages
Global
From €4017EUR$4,490USD£3,436GBP
- Report
- August 2026
- 337 Pages
Global
From €2237EUR$2,500USD£1,913GBP
- Clinical Trials
- August 2025
- 2906 Pages
Global
From €3087EUR$3,450USD£2,640GBP
- Report
- April 2026
- 160 Pages
Global
From €2971EUR$3,320USD£2,540GBP
€3713EUR$4,150USD£3,175GBP
- Report
- November 2025
- 150 Pages
Global
From €4340EUR$4,850USD£3,711GBP
- Report
- November 2025
- 150 Pages
Global
From €4340EUR$4,850USD£3,711GBP
- Report
- April 2026
- 99 Pages
Global
From €3500EUR$4,190USD£3,098GBP
- Report
- April 2024
- 318 Pages
Global
From €5265EUR$6,090USD£4,350GBP
- Report
- June 2025
- 83 Pages
United States
From €5324EUR$5,950USD£4,553GBP

The Immune Disorders Drugs market includes drugs used to treat Inflammatory Bowel Disease (IBD). IBD is a chronic condition that causes inflammation of the digestive tract, leading to abdominal pain, diarrhea, and other symptoms. IBD drugs are used to reduce inflammation and improve symptoms. These drugs include corticosteroids, immunomodulators, biologics, and other medications. Corticosteroids are used to reduce inflammation and suppress the immune system, while immunomodulators are used to modify the immune system's response to inflammation. Biologics are used to target specific molecules involved in the inflammatory process.
Some companies in the IBD drug market include AbbVie, Amgen, AstraZeneca, Boehringer Ingelheim, Janssen, Merck, Pfizer, and Takeda. Show Less Read more